Blueprint Medicines Corporation - stock earnings
BPMC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -110.9 million USD | 72.0 million USD |
| 2023Q3 | -133.7 million USD | 56.6 million USD |
| 2023Q2 | -132.8 million USD | 57.6 million USD |
| 2023Q1 | -129.6 million USD | 63.3 million USD |
| 2022Q4 | -158.6 million USD | 38.8 million USD |
| 2022Q3 | -133.2 million USD | 66.0 million USD |
| 2022Q2 | -159.7 million USD | 36.5 million USD |
| 2022Q1 | -106.0 million USD | 62.7 million USD |
| 2021Q4 | -318.7 million USD | 107.0 million USD |
| 2021Q3 | -117.2 million USD | 24.2 million USD |
| 2021Q2 | -108.4 million USD | 27.3 million USD |
| 2021Q1 | -99.7 million USD | 21.6 million USD |
| 2020Q4 | -85.7 million USD | 34.1 million USD |
| 2020Q3 | 634.0 million USD | 745.1 million USD |
| 2020Q2 | -123.5 million USD | 8.3 million USD |
| 2020Q1 | -111.0 million USD | 6.2 million USD |
| 2019Q4 | -66.3 million USD | 51.5 million USD |
| 2019Q3 | -94.3 million USD | 9.1 million USD |
| 2019Q2 | -99.7 million USD | 5.1 million USD |
| 2019Q1 | -87.4 million USD | 730000 USD |
| 2018Q4 | -80.3 million USD | 1.0 million USD |
| 2018Q3 | -72.7 million USD | 1.1 million USD |
| 2018Q2 | -27.0 million USD | 41.4 million USD |
| 2018Q1 | -56.5 million USD | 954000 USD |
| 2017Q4 | -49.0 million USD | 1.6 million USD |
| 2017Q3 | -37.7 million USD | 8.1 million USD |
| 2017Q2 | -33.4 million USD | 5.9 million USD |
| 2017Q1 | -28.0 million USD | 5.8 million USD |
| 2016Q4 | -21.3 million USD | 7.7 million USD |
| 2016Q3 | -16.8 million USD | 6.2 million USD |
| 2016Q2 | -18.9 million USD | 7.1 million USD |
| 2016Q1 | -15.5 million USD | 6.9 million USD |
| 2015Q4 | -15.6 million USD | 4.6 million USD |
| 2015Q3 | -12.6 million USD | 3.4 million USD |
| 2015Q2 | -13.0 million USD | 2.7 million USD |
| 2015Q1 | -11.6 million USD | 652000 USD |
| 2014Q4 | -14.5 million USD | ? USD |
| 2014Q3 | -10.5 million USD | ? USD |
| 2014Q2 | -8.3 million USD | ? USD |
| 2014Q1 | -7.0 million USD | ? USD |
BPMC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -507.0 million USD | 249.4 million USD |
| 2022 | -557.5 million USD | 204.0 million USD |
| 2021 | -644.1 million USD | 180.1 million USD |
| 2020 | 313.9 million USD | 793.7 million USD |
| 2019 | -328.7 million USD | 66.5 million USD |
| 2018 | -236.6 million USD | 44.5 million USD |
| 2017 | -148.1 million USD | 21.4 million USD |
| 2016 | -72.5 million USD | 27.8 million USD |
| 2015 | -52.8 million USD | 11.4 million USD |
| 2014 | -40.3 million USD | ? USD |
| 2013 | -20.9 million USD | ? USD |
BPMC
Price: $93
52 week price:
Earnings Per Share: -8.37 USD
P/E Ratio: -8.65
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 807200
Ebitda: -37.3 millionMarket Capitalization: 5.6 billion